MedPath

ROSEMONT PHARMACEUTICALS LIMITED

🇬🇧United Kingdom
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

71

EMC:71

Drug Approvals

Sildenafil 10 mg/ml Oral suspension

Approval Date
Jul 7, 2025
EMC

Carbocisteine 750mg/5ml sugar-free syrup

Approval Date
Jul 7, 2025
EMC

Methotrexate 2mg/ml Oral Solution

Approval Date
Jul 7, 2025
EMC

Methadose Diluent

Approval Date
Jul 7, 2025
EMC

Frusol 20mg/5ml Oral Solution

Approval Date
Jul 7, 2025
EMC

Dipyridamole 50mg/5ml Oral Suspension

Approval Date
Jul 7, 2025
EMC

Ondansetron 8mg/5ml oral solution

Approval Date
Jul 7, 2025
EMC
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 8
  • Next

Clinical Trials

No trials found

News

Perrigo Receives FDA Approval for Generic Nexium 24HR

Perrigo has secured FDA approval for its over-the-counter store brand equivalent of Nexium 24HR (esomeprazole magnesium capsules).

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.